| Early Palliative Care on Quality of Life of Advanced Cancer Patients (NCT02988635) | Azienda Ospedaliero-Universitaria di Parma | 2014-11-01 |
| GEM/Cisplatin/S-1 vs GEM/Cisplatin for Biliary Tract Cancer (NCT02182778) | Kansai Hepatobiliary Oncology Group | 2014-07-09 |
| Extracellular RNA Markers of Liver Disease and Cancer (NCT02908048) | Mayo Clinic | 2014-07-01 |
| Covered Versus Uncovered Biliary Stents for Biliary Malignancies (NCT02102984) | Nuovo Ospedale Civile S.Agostino Estense | 2014-04-01 |
| Multibending vs Conventional Endoscope for Direct Peroral Cholangioscopy (NCT02189421) | Soonchunhyang University Hospital | 2014-04-01 |
| Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers (NCT01926236) | The Christie NHS Foundation Trust | 2014-02-01 |
| X-MAS Biliary Study With Covered Biliary Stent (NCT01899976) | Medinol Ltd. | 2013-08-01 |
| Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer (NCT01917617) | Kansai Hepatobiliary Oncology Group | 2013-05-22 |
| Vessel Resection and Reconstruction of Biliary Tract Cancers (NCT01861483) | Kansai Hepatobiliary Oncology Group | 2013-03-01 |
| Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer (NCT01815307) | Kansai Hepatobiliary Oncology Group | 2013-01-01 |
| Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions (NCT02670265) | University Medicine Greifswald | 2012-06-01 |
| A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy (NCT01713387) | Kansai Hepatobiliary Oncology Group | 2012-04-01 |
| Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery (NCT01657383) | Wake Forest University Health Sciences | 2012-04-01 |
| Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB (NCT01589328) | National Cancer Center, Korea | 2012-03-15 |
| Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas (NCT01572324) | Peking University | 2012-03-01 |
| Endoscopic Therapy of Malignant Bile Duct Strictures (NCT01543607) | Massachusetts General Hospital | 2012-02-01 |
| Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control (NCT02002806) | Indiana University | 2012-01-01 |
| Second Line Therapy in Advanced Biliary Tract Cancer (NCT01530503) | IRCCS San Raffaele | 2011-11-01 |
| Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer (NCT01494363) | Soon Chun Hyang University | 2011-10-01 |
| Comparison Between Winged Versus Traditional Plastic Stents for Biliary Drainage (NCT06960733) | University of Leipzig | 2011-06-01 |
| Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer (NCT01308840) | University of Rochester | 2010-12-01 |
| Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer (NCT01284413) | Kansai Hepatobiliary Oncology Group | 2010-12-01 |
| Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer (NCT01291615) | Kansai Hepatobiliary Oncology Group | 2010-12-01 |
| Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract Cancer (NCT01234051) | Korean South West Oncology Group | 2010-11-01 |
| Case Series Study of Biliary Tract Cancer Patients in Japan (NCT01294085) | Kansai Hepatobiliary Oncology Group | 2010-11-01 |
| Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma) (NCT01180153) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer (NCT01811277) | Peking University | 2010-07-01 |
| Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis (NCT04801719) | Brno University Hospital | 2010-01-04 |
| A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer (NCT00955721) | University of Miami | 2009-08-01 |
| A Study of FOLFOX6 With Bevacizumab for Biliary System Carcinoma (NCT00881504) | Georgetown University | 2009-06-01 |
| Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer (NCT00753675) | Genzyme, a Sanofi Company | 2008-10-01 |
| Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer (NCT00832689) | Yonsei University | 2008-06-01 |
| Phase II Study of Gemcitabine and TS-1 in Biliary Trat Cancer (NCT01171755) | Samsung Medical Center | 2008-02-01 |
| Cyberknife Radiosurgery Boost for Hilar Cholangiocarcinoma (Klatskin Tumor) (NCT00630890) | University of California, San Francisco | 2007-10-01 |
| Storage of Bile From Routine Procedures to Study Risk Factors (NCT00414843) | Indiana University | 2006-12-01 |
| Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer (NCT00380588) | Eli Lilly and Company | 2006-09-01 |
| Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer (NCT00361231) | Massachusetts General Hospital | 2006-05-01 |
| Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer (NCT00142480) | Massachusetts General Hospital | 2004-12-01 |
| XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors (NCT00090025) | Helsinn Healthcare SA | 2004-09-01 |
| Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer (NCT00123825) | Dana-Farber Cancer Institute | 2002-07-01 |
| A Population-Based Case-Control Study of Biliary Tract Cancers in Shanghai, China (NCT00339560) | National Cancer Institute (NCI) | 1997-05-16 |